日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Forecasting Waitlist Trajectories for Patients With Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis: A Neural Network Competing Risk Analysis

预测代谢功能障碍相关脂肪性肝炎肝硬化患者的等待名单轨迹:一种神经网络竞争风险分析

Punchhi, Gopika; Sun, Yingji; Tan, Eunice; Hlaing, Naomi Khaing Than; Liu, Chang; Asrani, Sumeet; Rambhatla, Sirisha; Bhat, Mamatha

Real-world survival outcomes of immunotherapy for advanced non-small cell lung cancer: A single-center retrospective review

晚期非小细胞肺癌免疫疗法的真实世界生存结果:单中心回顾性研究

Punchhi, Gopika; Hussein, Abdulkadir; Kulkarni, Swati

Modernising physician resource planning: a national interactive web platform for Canadian medical trainees

医师资源规划现代化:面向加拿大医学培训人员的国家级互动网络平台

Bourcier, D; Collins, B W; Tanya, S M; Basu, M; Sayal, A P; Moolla, S; Dong, A; Balas, M; Molcak, H; Punchhi, G

Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease

酒精相关性肝病早期肝移植与标准肝移植的疗效评价

Herrick-Reynolds, Kayleigh M; Punchhi, Gopika; Greenberg, Ross S; Strauss, Alexandra T; Boyarsky, Brian J; Weeks-Groh, Sharon R; Krach, Michelle R; Anders, Robert A; Gurakar, Ahmet; Chen, Po-Hung; Segev, Dorry L; King, Elizabeth A; Philosophe, Benjamin; Ottman, Shane E; Wesson, Russell N; Garonzik-Wang, Jacqueline M; Cameron, Andrew M

IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations

IDH 突变低级别(WHO II/III 级)星形细胞瘤可根据 CDKN2A、CDK4 和 PDGFRA 拷贝数变异进行风险分层

Rui Ryan Yang, Zhi-Feng Shi, Zhen-Yu Zhang, Aden Ka-Yin Chan, Abudumijiti Aibaidula, Wei-Wei Wang, Johnny Sheung Him Kwan, Wai Sang Poon, Hong Chen, Wen-Cai Li, Nellie Yuk-Fei Chung, Gopika Punchhi, William Ching-Yuen Chu, Ivan Sik-Hei Chan, Xian-Zhi Liu, Ying Mao, Kay Ka-Wai Li, Ho-Keung Ng